SCHEMBL4953015

SCHEMBL4953015

C=CCn1c(=O)c2[nH]c(C)nc2n(CCCC)c1=O

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.52
ADORA2A P29274 3/20 0.52
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52
ADORA1 P30542 2/20 0.47
ADORA3 P0DMS8 1/20 0.47
PDE2A O00408 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
SIRT1 Q96EB6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10855008 0.96 ADORA2A (0.49) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL10856290 0.92 ADORA2B (0.61) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL9122677 0.89 ADORA2B (0.55) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL7918903 0.88 ADORA1 (0.57) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL11072744 0.86 ADORA2B (0.51) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL10856971 0.85 SIRT1 (0.61) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL10859893 0.85 SIRT1 (0.61) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL11072524 0.85 SIRT1 (0.55) ADORA2BADORA2AADORA1ADORA3PDE2A
SCHEMBL11069719 0.84 PDE2A (0.54) ADORA2BADORA2APDE4APDE4BPDE4C
SCHEMBL10857602 0.82 PDE1A (0.66) ADORA2BADORA2APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0039780-B1 DI- OR TRISUBSTITUTED XANTHINES WITH NEUROLEPTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-04-10 EP claimed
US-4469698-A SEDATIVES, TRANQUILIZERS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-09-04 US claimed
EP-0039780-A1 Di- or trisubstituted xanthines with neuroleptic activity, process for their preparation and pharmaceutical preparations containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1981-11-18 EP claimed
EP-1896619-A2 TARGETS FOR INHIBITING HCV REPLICATION Merck & Co., Inc. (US) 2008-03-12 EP disclosed
WO-2007001928-A2 TARGETS FOR INHIBITING HCV REPLICATION MERCK & CO., INC. (US) 2007-01-04 WO disclosed
US-4581451-A ALKYLATION AND CYCLIZATION OF A URACIL COMPOUND NESTEC S.A. (CH) 1986-04-08 US disclosed
EP-0039780-B1 DI- OR TRISUBSTITUTED XANTHINES WITH NEUROLEPTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-04-10 EP disclosed
US-4469698-A SEDATIVES, TRANQUILIZERS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-09-04 US disclosed
EP-0039780-A1 Di- or trisubstituted xanthines with neuroleptic activity, process for their preparation and pharmaceutical preparations containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1981-11-18 EP disclosed